Spruce Biosciences, Inc. Common Stock (NASDAQ: SPRB) last traded at $44.05, down 3.27% on the session. The quote above updates while this page is open; the figures below are drawn from Spruce Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Spruce Biosciences, Inc. Common Stock trades on NASDAQ under the ticker SPRB. Its market capitalisation is $126.60 million.
Valuation measures for Spruce Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $126.60M |
|---|---|
| Enterprise value | $49.43M |
| Price / book | 1.51 |
| Beta | 1.41 |
Trailing-twelve-month figures tagged in Spruce Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$51.35M |
|---|
| Return on equity | -61.33% |
|---|
| Cash | $96.30M |
|---|
Range and volume for SPRB over the past 52 weeks.
| 52-week high | $188.25 |
|---|---|
| 52-week low | $40.33 |
| Volume | 83.8K |
| Average volume | 77.8K |
| Previous close | $45.54 |
Invest a chosen dollar amount in Spruce Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell SPRB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.